HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Shu-Hsun Chu Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chu, S.-H. Articles by Wang, C.-J. Search for Related Content PubMed PubMed Citation Articles by Chu, S.-H. Articles by Wang, C.-J.

Ann Thorac Surg 1991;52:791-796
© 1991 The Society of Thoracic Surgeons

---

Articles

Thyroid hormone changes cardiovascular surgery and clinical implications

Departments of Surgery and Medicine, National Taiwan University Hospital, Taipei, Taiwan, Republic of China

Accepted for publication April 16, 1991.

^_* Address reprint requests to Dr Chu, National Taiwan University Hospital, 1, Chang-Te St, Taipei, Taiwan, Republic of China.

Alterations in serum concentrations of total triiodothyronine (TT₃), total thyroxine (TT₄), and thyroid-stimulating hormone (TSH) frequently occur in patients with nonthyroidal illnesses. These changes correlate with the severity of the illness and the prognosis. In this study, 44 patients undergoing a cardiovascular operation had significant declines in serum TT₃ and TT₄ levels during cardiopulmonary bypass and thereafter. Serum TT₃ and TT₄ concentrations reached their nadir at 30 minutes after the start of cardiopulmonary bypass with values (mean ± standard error of the mean) of 0.77 ± 0.12 nmol/L (50.4 ± 7.6 ng/dL) and 68.2 ± 10.2 nmol/L (5.30 ± 0.79 µg/dL), respectively. The mean serum concentrations of TSH and TT₄ returned to preoperative levels by the sixth day after operation, whereas TT₃ levels remained low throughout the study period. The patients whose recovery was uneventful had higher serum TT₃, TT₄, and TSH levels than those who had complications or died. The trend toward recovery was initiated by a sharp increase in the serum TSH level and increases in serum TT₃ and TT₄ concentrations on the fourth day after operation. Patients with complications either did not show these changes or had only a transient increase in TT₃ and TT₄ levels. All of the patients had a normal serum free T₄ level before anesthesia. Those with an uneventful recovery had a higher serum free T₄ level on the sixth day after operation than those with complications. Two patients in the latter group had serum free T₄ levels less than normal at that time. The alterations in serum TT₄, TT₃, and TSH concentrations has no correlation with drugs (furosemide, dopamine hydrochloride, dobutamine hydrochloride, isoproterenol hydrochloride, norepinephrine, or epinephrine) administered during the study period. In summary, serum TT₃, TT₄ and TSH levels declined in patients undergoing a cardiovascular operation, especially in those who had complications or died. The administration of catecholamines or furosemide was not an important factor in the development of abnormal thyroid function test results in our study.

This article has been cited by other articles:

				T. Velissaris, A. T. M. Tang, P. J. Wood, D. A. Hett, and S. K. Ohri Thyroid function during coronary surgery with and without cardiopulmonary bypass Eur J Cardiothorac Surg, July 1, 2009; 36(1): 148 - 154. [Abstract] [Full Text] [PDF]

				R. Salenger, J. S. Gammie, and T. J. Vander Salm Postoperative Care of Cardiac Surgical Patients Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469. [Full Text]

				C. J. O'Connor, R. March, and K. J. Tuman Severe Myxedema After Cardiopulmonary Bypass Anesth. Analg., January 1, 2003; 96(1): 62 - 64. [Abstract] [Full Text] [PDF]

				D. L Stewart, N. Ssemakula, D. R MacMillan, L J. Goldsmith, and L. N Cook Thyroid function in neonates with severe respiratory failure on extracorporeal membrane oxygenation Perfusion, December 1, 2001; 16(6): 469 - 475. [Abstract] [PDF]

				R. D. Mainwaring, E. Capparelli, K. Schell, M. Acosta, and J. C. Nelson Pharmacokinetic Evaluation of Triiodothyronine Supplementation in Children After Modified Fontan Procedure Circulation, March 28, 2000; 101(12): 1423 - 1429. [Abstract] [Full Text] [PDF]

				E. Bennett-Guerrero, J. L. Jimenez, W. D. White, E. B. D'Amico, B. I. Baldwin, D. A. Schwinn, Duke T3 Study Group, N. P. Bouknight, C. M. Chuey, F. M. Clements, et al. Cardiovascular Effects of Intravenous Triiodothyronine in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Randomized, Double-blind, Placebo-Controlled Trial JAMA, March 6, 1996; 275(9): 687 - 692. [Abstract] [PDF]

				M. G. Katz, A. J. Cohen, H. Schwalb, J. Segal, G. Merin, and A. Schachner Interaction of thyroid hormone and heparin in postischemic myocardial recovery Ann. Thorac. Surg., November 1, 1995; 60(5): 1215 - 1218. [Abstract] [PDF]

				B. Murzi, G. Iervasi, S. Masini, R. Moschetti, V. Vanini, G. Zucchelli, and A. Biagini Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass Ann. Thorac. Surg., February 1, 1995; 59(2): 481 - 485. [Abstract] [PDF]

				C. M. Dyke, M. Ding, A. S. Abd-Elfattah, K. Loesser, R. J. Dignan, A. S. Wechsler, and D. R. Salter Effects of triiodothyronine supplementation after myocardial ischemia Ann. Thorac. Surg., August 1, 1993; 56(2): 215 - 222. [Abstract] [PDF]

				S. W. Downing and L. H. Edmunds Jr Release of vasoactive substances during cardiopulmonary bypass Ann. Thorac. Surg., December 1, 1992; 54(6): 1236 - 1243. [Abstract] [PDF]